The pharmaceutical industry faces immense challenges in bringing new drugs to market, with the traditional process design and tech transfer methods proving to be inefficient and costly. These conventional approaches often result in fragmented data, lack of collaboration, and excessive resource usage, leading to extended timeframes and increased costs for drug development. With the average tech transfer taking around 20 months and involving numerous cross-functional experts, the need for a more streamlined approach is critical. Driving digital transformation in the lab is critical by integrating advanced technologies into the lab environment, allowing for faster, more efficient development processes that bridge the gap between R&D and production.
By following the approach of the process design and tech transfer digital thread, companies can rapidly develop an optimized drug product formulation and an associated robust manufacturing process. This enables faster, more efficient scale-ups from the pre-clinical phase to clinical trials and onto commercial manufacturing. This comprehensive approach helps reduce time-to-market and advances collaboration by powering efficient knowledge transfer. It enhances drug manufacturability while keeping project costs, schedules, transparency and compliance under control.
Download our ebook and discover how following the process design and tech transfer approach can streamline the journey from lab to production.